Prevalence of thyroid diseases in familial adenomatous polyposis: a systematic review and meta-analysis
- 121 Downloads
Thyroid cancer (TC) is a known extra-intestinal manifestation and contributes to the mortality and morbidity in patients with familial adenomatous polyposis (FAP). Its exact prevalence is not well established and recent studies have shown an increasing number of TC in this patient population. The prevalence of benign thyroid masses and endocrinologic thyroid disorders are also poorly described. We conducted a systematic review and meta-analysis by using a random-effects model to characterize TC and estimated the prevalence of thyroid diseases in FAP patients. Twelve studies (n = 9821) were included. Pooled prevalence of TC, benign thyroid masses, and endocrinologic thyroid disorders in FAP were 2.6% [95% confidence interval (CI) 1.3–4.8], 48.8% [95% CI 33.8–64.0], and 6.9% [95% CI 4.5–10.3] respectively. Subgroup analyses revealed higher prevalence of TC in studies with fewer participants, studies that used screening ultrasound to diagnose TC, and studies that were published after 2002. TC diagnosis preceded the diagnosis of FAP in 34% of the patients. The means age at diagnosis of FAP and TC were 29 and 31 years, respectively. 95% of the patients were female and the most common pathology was of papillary subtype (83.3%). Most mutations (79.2%) were located at the 5′ end of APC gene. In summary, benign thyroid disorders are common in FAP, yet, TC is an uncommon phenomenon. Certain patient subset, such as young female with APC mutation at the 5′ end, might benefit from routine surveillance ultrasound.
KeywordsFamilial adenomatous polyposis Thyroid cancer Thyroid diseases
We would like to express our gratitude to Marian MacMaster and Joan Yanicke, our lovely librarians at the Medical Library, Metrowest Medical Center, for checking the relevant search terms and helping us retrieve all the relevant articles.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 5.Howlader N, Noone AM, Krapcho M et al (2016) SEER Cancer Statistics Review, 1975–2013. National Cancer Institute, BethesdaGoogle Scholar
- 6.Steinhagen E, Guillem JG, Chang G et al (2012) The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized. Clin Colorectal Cancer 11(4):304–308. https://doi.org/10.1016/j.clcc.2012.01.006 CrossRefPubMedGoogle Scholar
- 20.Ho JW, Chu KM, Tse CW, Yuen ST (2002) Phenotype and management of patients with familial adenomatous polyposis in Hong Kong: perspective of the Hereditary Gastrointestinal Cancer Registry. Hong Kong medical journal = Xianggang yi xue za zhi/Hong Kong. Acad Med 8(5):342–347Google Scholar
- 30.Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Cetta F, Montalto G, Gori M, Curia MC, Cama A, Olschwang S (2000) Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 85(1):286–292. https://doi.org/10.1210/jcem.85.1.6254 PubMedGoogle Scholar
- 46.Mohammadzadeh Z, Ghazisaeedi M, Nahvijou A, Kalhori SR, Davoodi S, Zendehdel K (2017) Systematic review of hospital based cancer registries (HBCRs): necessary tool to improve quality of care in cancer patients. Asian Pac J Cancer Prev 18(8):2027–2033. https://doi.org/10.22034/APJCP.2017.18.8.2027 PubMedPubMedCentralGoogle Scholar